7 results on '"O'Connor, Matthew S."'
Search Results
2. Rapid enrichment of mitochondria from mammalian cell cultures using digitonin
- Author
-
Dixit, Bhavna, Vanhoozer, Shon, Anti, Nana Abena, O'Connor, Matthew S., and Boominathan, Amutha
- Published
- 2021
- Full Text
- View/download PDF
3. Telosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric Proteins.
- Author
-
Liu, Dan, O'Connor, Matthew S., Qin, Jun, and Songyang, Zhou
- Subjects
- *
TELOMERES , *PROTEINS , *CHROMOSOMES , *CARRIER proteins , *MOLECULAR weights , *BIOCHEMISTRY - Abstract
In mammalian cells, telomere-binding proteins TRF1 and TRF2 play crucial roles in telomere biology. They interact with several other telomere regulators including TIN2, PTOP, POT1, and RAP1 to ensure proper maintenance of telomeres. TRF1 and TRF2 are believed to exert distinct functions. TRF1 forms a complex with TIN2, PTOP, and POT1 and regulates telomere length, whereas TRF2 mediates t-loop formation and end protection. However, whether cross-talk occurs between the TRF1 and TRF2 complexes and how the signals from these complexes are integrated for telomere maintenance remain to be elucidated. Through gel filtration and co-immunoprecipitation experiments, we found that TRF1 and TRF2 are in fact subunits of a telomere-associated high molecular weight complex (telosome) that also contains POT1, PTOP, RAP1, and TIN2. We demonstrated that the TRF1-interacting protein TIN2 binds TRF2 directly and in vivo, thereby bridging TRF2 to TRF1. Consistent with this multi-protein telosome model, stripping TRF1 off the telomeres by expressing tankyrase reduced telomere recruitment of not only TIN2 but also TRF2. These results help to unify previous observations and suggest that telomere maintenance depends on the multi-subunit telosome. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
4. The Human Rap1 Protein Complex and Modulation of Telomere Length.
- Author
-
O'Connor, Matthew S., Safari, Amin, Dan Liu, Jun Qin, and Zhou Songyang
- Subjects
- *
TELOMERES , *CARRIER proteins , *PROTEIN binding , *PROTEIN-protein interactions , *MOLECULAR biology , *BIOCHEMISTRY - Abstract
Proper maintenance of telomere length and structure is necessary for normal proliferation of mammalian cells. Mammalian telomere length is regulated by a number of proteins including human repressor activator protein (hRap1), a known association factor of TRF2. To further delineate hRap1 function and its associated proteins, we affinity-purified and identified the hRap1 protein complex through mass spectrometry analysis. In addition to TRF2, we found DNA repair proteins Rad50, Mre11, PARP1 (poly(ADP-ribose) polymerase), and Ku86/Ku70 to be in this telomeric complex. We demonstrated by deletional analysis that Rad-50/Mre-11 and Ku86 were recruited to hRap1 independent of TRF2. PARP1, however, most likely interacted with hRap1 through TRF2. Interestingly, knockdown of endogenous hRap1 expression by small hairpin interference RNA resulted in longer telomeres. In addition, overexpression of full-length and mutant hRap1 that lacked the BRCA1 C-terminal domain functioned as dominant negatives and extended telomeres. Deletion of a novel linker domain of hRap1 (residues 199–223), however, abolished the dominant negative effect of hRap1 over-expression. These results indicate that hRap1 negatively regulates telomere length in vivo and suggest that the linker region of hRap1 may modulate the recruitment of negative regulators of telomere length. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
5. Unraveling the molecular dynamics of sugammadex-rocuronium complexation: A blueprint for cyclodextrin drug design.
- Author
-
Anderson, Amelia, García-Fandiño, Rebeca, Piñeiro, Ángel, and O'Connor, Matthew S.
- Subjects
- *
CYCLODEXTRINS , *DRUG design , *NEUROMUSCULAR blocking agents , *SUGAMMADEX , *DYNAMICS , *MOLECULAR dynamics , *INCLUSION compounds - Abstract
Sugammadex, marketed as Bridion™, is an approved cyclodextrin (CD) based drug for the reversal of neuromuscular blockade in adults undergoing surgery. Sugammadex forms an inclusion complex with the neuromuscular blocking agent (NMBA) rocuronium, allowing rapid reversal of muscle paralysis. In silico methods have been developed for studying CD inclusion complexes, aimed at accurately predicting their structural, energetic, dynamic, and kinetic properties, as well as binding constants. Here, a computational study aimed at characterizing the sugammadex-rocuronium system from the perspective of docking calculations, free molecular dynamics (MD) simulations, and biased metadynamics simulations with potential of mean force (PMF) calculations is presented. The aim is to provide detailed information about this system, as well as to use it as a model system for validation of the methods. This method predicts results in line with experimental evidence for both the optimal structure and the quantitative value for the binding constant. Interestingly, there is a less profound preference for the orientation than might be assumed based on electrostatic interactions, suggesting that both orientations may exist in solution. These results show that this technology can efficiently analyze CD inclusion complexes and could be used to facilitate the development and optimization of novel applications for CDs. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Addressing the complexities in measuring cyclodextrin-sterol binding constants: A multidimensional study.
- Author
-
Anderson, Amelia M., Manet, Ilse, Malanga, Milo, Clemens, Daniel M., Sadrerafi, Keivan, Piñeiro, Ángel, García-Fandiño, Rebeca, and O'Connor, Matthew S.
- Subjects
- *
BINDING constant , *ISOTHERMAL titration calorimetry , *ATHEROSCLEROTIC plaque , *BINDING site assay , *INCLUSION compounds - Abstract
A class of cyclodextrin (CD) dimers has emerged as a potential new treatment for atherosclerosis; they work by forming strong, soluble inclusion complexes with oxysterols, allowing the body to reduce and heal arterial plaques. However, characterizing the interactions between CD dimers and oxysterols presents formidable challenges due to low sterol solubility, the synthesis of modified CDs resulting in varying number and position of molecular substitutions, and the diversity of interaction mechanisms. To address these challenges and illuminate the nuances of CD-sterol interactions, we have used multiple orthogonal approaches for a comprehensive characterization. Results obtained from three independent techniques - metadynamics simulations, competitive isothermal titration calorimetry, and circular dichroism - to quantify CD-sterol binding are presented. The objective of this study is to obtain the binding constants and gain insights into the intricate nature of the system, while accounting for the advantages and limitations of each method. Notably, our findings demonstrate ∼1000× stronger affinity of the CD dimer for 7-ketocholesterol in comparison to cholesterol for the 1:1 complex in direct binding assays. These methodologies and findings not only enhance our understanding of CD dimer-sterol interactions, but could also be generally applicable to prediction and quantification of other challenging host-guest complex systems. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Cyclodextrin dimers: A versatile approach to optimizing encapsulation and their application to therapeutic extraction of toxic oxysterols.
- Author
-
Anderson, Amelia M., Kirtadze, Tamari, Malanga, Milo, Dinh, Darren, Barnes, Carolyn, Campo, Angielyn, Clemens, Daniel M., Garcia-Fandiño, Rebeca, Piñeiro, Ángel, and O'Connor, Matthew S.
- Subjects
- *
OXYSTEROLS , *DRUG design , *DIMERS , *HYDROXYCHOLESTEROLS , *THERAPEUTICS , *BIOMOLECULES , *RETINAL degeneration - Abstract
[Display omitted] • 7KC is an atherogenic oxysterol which can be solubilized by cyclodextrins (CDs). • Engineered CD dimers solubilize 7KC with greater affinity than monomers. • In silico and in vitro methods were used to optimize CD engineering. • Human monocytes can be rescued from 7KC toxicity by certain cyclodextrin dimers. • Optimized CD dimers are nontoxic to mice, suggesting they could be used as APIs. We have developed a novel class of specifically engineered, dimerized cyclodextrin (CD) nanostructures for the encapsulation of toxic biomolecules such as 7-ketocholesterol (7KC). 7KC accumulates over time and causes dysfunction in many cell types, linking it to several age-related diseases including atherosclerosis and age-related macular degeneration (AMD). Presently, treatments for these diseases are invasive, expensive, and show limited benefits. CDs are cyclic glucose oligomers utilized to capture small, hydrophobic molecules. Here, a combination of in silico , in vitro, and ex vivo methods is used to implement a synergistic rational drug design strategy for developing CDs to remove atherogenic 7KC from cells and tissues. Mechanisms by which CDs encapsulate sterols are discussed, and we conclude that covalently linked head-to-head dimers of βCDs have substantially improved affinity for 7KC compared to monomers. We find that inclusion complexes can be stabilized or destabilized in ways that allow the design of CD dimers with increased 7KC selectivity while maintaining an excellent safety profile. These CD dimers are being developed as therapeutics to treat atherosclerosis and other debilitating diseases of aging. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.